| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PPP1R13L ADAM8 ITGB4 ITGB7 PTPRF PTPRJ PI4KA DLG1 KIF5B PLEC LILRA2 FN1 TNC CPE EEF1G CDH22 TENM3 EMD CTNND2 ARHGAP18 TNR CDH6 CDH7 CDH12 CDH18 | 1.01e-09 | 599 | 195 | 25 | GO:0050839 |
| GeneOntologyMolecularFunction | cadherin binding | PPP1R13L PTPRJ PI4KA DLG1 KIF5B PLEC EEF1G CDH22 EMD CTNND2 ARHGAP18 CDH6 CDH7 CDH12 CDH18 | 1.29e-06 | 339 | 195 | 15 | GO:0045296 |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.76e-06 | 120 | 195 | 9 | GO:0008013 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.10e-04 | 149 | 195 | 8 | GO:1990782 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.38e-04 | 51 | 195 | 5 | GO:0043394 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHB5 ADAM8 SLIT2 FAT1 HEG1 SYT13 ASAH2 FAT3 PCLO THBS2 CDH22 SLIT1 RASEF PADI6 CDH6 PCDH8 CDH7 CDH12 CDH18 | 1.43e-04 | 749 | 195 | 19 | GO:0005509 |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 DLG5 MAP1B PSG6 MYOC PSG11 HIPK1 PCDHB5 IQSEC2 WASF3 CLASP2 ITGB4 SLIT2 HEG1 PTPRF PTPRJ DLG1 KIF5B PLEC ROCK2 SDK2 LAMTOR2 FN1 TNC PCLO THBS2 CDH22 TENM3 SLIT1 CTNND2 MDGA1 TNR CDH6 PCDH8 CDH7 CDH12 CDH18 | 2.16e-13 | 974 | 192 | 37 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB3 DLG5 MAP1B MYOC HIPK1 PCDHB5 IQSEC2 CLASP2 ITGB4 SLIT2 PTPRJ DLG1 PLEC ROCK2 SDK2 FN1 PCLO THBS2 CDH22 SLIT1 MDGA1 CDH6 CDH7 CDH12 CDH18 | 1.28e-10 | 569 | 192 | 25 | GO:0034329 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PSG6 PSG11 PCDHB5 FAT1 PTPRF SDK2 FAT3 CDH22 TENM3 CDH6 PCDH8 CDH7 CDH12 CDH18 | 2.49e-09 | 187 | 192 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 MAP1B WASF3 MCF2 CLASP2 ADAM8 SLIT2 FAT1 HEG1 PTPRF PTPRJ PTPRQ VPS13A DLG1 KIF5B PLEC SDC2 PLXNA2 ROCK2 FN1 FAT3 NR4A3 FRYL CDH22 SLIT1 EIF2AK4 RND2 CTNND2 ARHGAP18 TNR CDH6 CDH7 CDH12 CDH18 | 4.87e-09 | 1194 | 192 | 34 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 DLG5 PSG6 PSG11 PCDHB5 ARID1A FOXA2 ADAM8 ITGB4 ITGB7 SLIT2 FAT1 PTPRF ADAMTS18 DLG1 PEAR1 SDK2 FAT3 NR4A3 NDFIP1 CDH22 TENM3 BRD7 CTNND2 MDGA1 TNR CDH6 PCDH8 CDH7 CDH12 CDH18 | 2.01e-08 | 1077 | 192 | 31 | GO:0098609 |
| GeneOntologyBiologicalProcess | adherens junction organization | 9.41e-08 | 61 | 192 | 8 | GO:0034332 | |
| GeneOntologyBiologicalProcess | synapse organization | EPHB3 DLG5 MAP1B PCDHB5 IQSEC2 WASF3 CLASP2 SLIT2 PTPRF DLG1 KIF5B ROCK2 SDK2 TNC PCLO THBS2 TENM3 SLIT1 CTNND2 MDGA1 TNR CDH6 PCDH8 | 1.12e-07 | 685 | 192 | 23 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PSG6 PSG11 PCDHB5 FAT1 PTPRF SDK2 FAT3 CDH22 TENM3 MDGA1 CDH6 PCDH8 CDH7 CDH12 CDH18 | 2.59e-07 | 313 | 192 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell junction organization | DLG5 PSG6 PSG11 HIPK1 HEG1 DLG1 PLEC ROCK2 CDH22 CDH6 CDH7 CDH12 CDH18 | 5.56e-07 | 246 | 192 | 13 | GO:0045216 |
| GeneOntologyBiologicalProcess | embryo development | KDM4C HIPK1 KBTBD8 NAGLU CLASP2 PPP1R13L BCOR ARID1A FOXA2 TRIP12 SLIT2 FREM2 HEG1 HOXC6 PTPRQ DLG1 DLX3 SGF29 PLXNA2 HAND2 CCDC40 ROCK2 TCF3 COL12A1 FN1 FOXN4 NR4A3 APOB AGBL4 KMT2D NR5A2 PADI6 PCDH8 | 1.25e-06 | 1437 | 192 | 33 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB3 DLG5 PSG6 MYOC PSG11 CLASP2 ARID1A FOXA2 ADAM8 NUAK1 ADAMDEC1 PTPRJ ADAMTS18 DLG1 PLXNA2 ROCK2 FN1 TNC NR4A3 NDFIP1 TENM3 BRD7 MDGA1 TNR PCDH8 | 1.79e-06 | 927 | 192 | 25 | GO:0030155 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | GABRR2 DLG5 PSG6 PSG11 HIPK1 NAGLU IKZF1 PPP1R13L BCOR ARID1A FOXA2 ITGB4 SLIT2 FAT1 HEG1 PTPRQ DLG1 DLX3 HAND2 CCDC40 SDK2 FOXN4 TNC FAT3 NR4A3 CPE DZANK1 TENM3 SLIT1 NR5A2 | 2.29e-06 | 1269 | 192 | 30 | GO:0009887 |
| GeneOntologyBiologicalProcess | eye development | GABRR2 HIPK1 NAGLU IKZF1 PPP1R13L ARID1A FREM2 FAT1 ADAMTS18 DLG1 HSF4 SDK2 B3GLCT FOXN4 FAT3 DZANK1 TENM3 | 2.74e-06 | 480 | 192 | 17 | GO:0001654 |
| GeneOntologyBiologicalProcess | visual system development | GABRR2 HIPK1 NAGLU IKZF1 PPP1R13L ARID1A FREM2 FAT1 ADAMTS18 DLG1 HSF4 SDK2 B3GLCT FOXN4 FAT3 DZANK1 TENM3 | 2.97e-06 | 483 | 192 | 17 | GO:0150063 |
| GeneOntologyBiologicalProcess | eye morphogenesis | GABRR2 HIPK1 NAGLU IKZF1 ARID1A FAT1 SDK2 FOXN4 FAT3 DZANK1 TENM3 | 3.48e-06 | 204 | 192 | 11 | GO:0048592 |
| GeneOntologyBiologicalProcess | sensory system development | GABRR2 HIPK1 NAGLU IKZF1 PPP1R13L ARID1A FREM2 FAT1 ADAMTS18 DLG1 HSF4 SDK2 B3GLCT FOXN4 FAT3 DZANK1 TENM3 | 3.70e-06 | 491 | 192 | 17 | GO:0048880 |
| GeneOntologyBiologicalProcess | neuron development | EPHB3 GABRR2 DLG5 TOX MAP1B MYOC NAGLU MCF2 CLASP2 SLIT2 PTPRF PTPRQ VPS13A KIF5B SDC2 PLXNA2 ACAP3 HAND2 ROCK2 FN1 TNC FAT3 NR4A3 FRYL AGBL4 DZANK1 TENM3 SLIT1 EIF2AK4 RND2 CTNND2 TNR | 5.17e-06 | 1463 | 192 | 32 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 6.80e-06 | 50 | 192 | 6 | GO:0044331 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 9.60e-06 | 53 | 192 | 6 | GO:0016339 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 1.23e-05 | 115 | 192 | 8 | GO:0150115 | |
| GeneOntologyBiologicalProcess | sensory organ development | GABRR2 HIPK1 NAGLU IKZF1 PPP1R13L ARID1A FREM2 FAT1 PTPRQ ADAMTS18 DLG1 HSF4 HAND2 SDK2 B3GLCT FOXN4 FAT3 NR4A3 DZANK1 TENM3 | 1.66e-05 | 730 | 192 | 20 | GO:0007423 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | GABRR2 HIPK1 NAGLU IKZF1 ARID1A FAT1 PTPRQ SDK2 FOXN4 FAT3 NR4A3 DZANK1 TENM3 | 2.10e-05 | 343 | 192 | 13 | GO:0090596 |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 2.75e-05 | 167 | 192 | 9 | GO:0007043 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 3.31e-05 | 171 | 192 | 9 | GO:0048593 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | EPHB3 DLG5 MAP1B MYOC IQSEC2 CLASP2 SLIT2 PTPRJ ROCK2 THBS2 SLIT1 MDGA1 | 3.46e-05 | 309 | 192 | 12 | GO:1901888 |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell proliferation | 3.85e-05 | 21 | 192 | 4 | GO:0061469 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 4.27e-05 | 42 | 192 | 5 | GO:0099560 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | DLG5 PSG6 MYOC PSG11 CLASP2 ADAM8 ADAMDEC1 ADAMTS18 DLG1 PLXNA2 TNC NDFIP1 TNR | 5.26e-05 | 375 | 192 | 13 | GO:0007162 |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 6.85e-05 | 108 | 192 | 7 | GO:0007044 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 7.56e-05 | 148 | 192 | 8 | GO:1902414 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | DLG5 NAGLU CLASP2 ARID1A FOXA2 ADAM8 SLIT2 FREM2 FAT1 HEG1 DLG1 DLX3 HAND2 CCDC40 ROCK2 FOXN4 TNC NR4A3 PCDH8 | 7.80e-05 | 750 | 192 | 19 | GO:0048729 |
| GeneOntologyBiologicalProcess | retina layer formation | 7.90e-05 | 25 | 192 | 4 | GO:0010842 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | EPHB3 DLG5 MAP1B IQSEC2 MBD1 WASF3 MCF2 SLIT2 PTPRF DLG1 PLXNA2 FN1 THBS2 SLIT1 RND2 MDGA1 TNR | 8.03e-05 | 625 | 192 | 17 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 8.14e-05 | 192 | 192 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | DLG5 TOX PSG6 PSG11 ARID1A ADAM8 PTPRJ ADAMTS18 DLG1 PEAR1 TCF3 LILRA2 FN1 NR4A3 NDFIP1 LAT BRD7 IRS2 SOS2 | 8.66e-05 | 756 | 192 | 19 | GO:0050865 |
| GeneOntologyBiologicalProcess | epithelium development | DLG5 EPPK1 MAP1B PSG6 PSG11 NAGLU CLASP2 ARID1A FOXA2 SLIT2 FREM2 FAT1 HEG1 PTPRQ DLG1 DLX3 PLEC HSF4 PLXNA2 HAND2 CCDC40 ROCK2 FOXN4 TNC RBM4 XDH RFX3 NR5A2 PCDH8 | 9.70e-05 | 1469 | 192 | 29 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | EPHB3 DLG5 PSG6 PSG11 ARID1A FOXA2 ADAM8 ADAMTS18 DLG1 NR4A3 NDFIP1 TENM3 BRD7 MDGA1 TNR PCDH8 | 1.11e-04 | 580 | 192 | 16 | GO:0022407 |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 1.48e-04 | 122 | 192 | 7 | GO:0061387 | |
| GeneOntologyBiologicalProcess | response to wounding | EPPK1 MAP1B PSG6 PSG11 NAGLU CLASP2 FOXA2 ITGB4 LYVE1 PTPRF PTPRJ ADAMTS18 PLEC PEAR1 FN1 TNC TNR | 1.52e-04 | 659 | 192 | 17 | GO:0009611 |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB3 DLG5 MAP1B PCDHB5 IQSEC2 SLIT2 SDK2 PCLO THBS2 SLIT1 MDGA1 | 1.54e-04 | 308 | 192 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 DLG5 TOX MAP1B MYOC MCF2 CLASP2 SLIT2 PTPRF VPS13A KIF5B SDC2 PLXNA2 ACAP3 ROCK2 FN1 TNC FAT3 NR4A3 FRYL TENM3 SLIT1 EIF2AK4 RND2 CTNND2 TNR | 1.57e-04 | 1285 | 192 | 26 | GO:0031175 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | GBF1 MYOC IQSEC2 MCF2 SLIT2 HEG1 ROCK2 ARHGEF5 RALGPS2 LAT CGNL1 RND2 ARHGAP27 ARHGAP18 SOS2 | 1.63e-04 | 538 | 192 | 15 | GO:0007264 |
| GeneOntologyBiologicalProcess | camera-type eye development | HIPK1 NAGLU IKZF1 PPP1R13L ARID1A FAT1 DLG1 HSF4 SDK2 B3GLCT FOXN4 FAT3 TENM3 | 1.88e-04 | 426 | 192 | 13 | GO:0043010 |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 1.96e-04 | 90 | 192 | 6 | GO:0060042 | |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 2.12e-04 | 13 | 192 | 3 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 2.12e-04 | 13 | 192 | 3 | GO:0048541 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB3 MAP1B MCF2 CLASP2 SLIT2 PTPRF PTPRQ KIF5B SDC2 PLXNA2 ROCK2 FN1 FAT3 NR4A3 SLIT1 RND2 CTNND2 TNR | 2.28e-04 | 748 | 192 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | DLG5 NAGLU CLASP2 ARID1A FOXA2 SLIT2 FREM2 FAT1 DLG1 DLX3 HAND2 CCDC40 ROCK2 FOXN4 TNC PCDH8 | 2.33e-04 | 619 | 192 | 16 | GO:0002009 |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 2.57e-04 | 3 | 192 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.71e-04 | 34 | 192 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | EPHB3 DLG5 MAP1B IQSEC2 SLIT2 PTPRF KIF5B ROCK2 THBS2 SLIT1 MDGA1 PCDH8 | 2.87e-04 | 387 | 192 | 12 | GO:0050807 |
| GeneOntologyBiologicalProcess | positive regulation of cell junction assembly | 2.88e-04 | 136 | 192 | 7 | GO:1901890 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | GBF1 MYOC IQSEC2 MCF2 SLIT2 HEG1 ARHGEF5 CGNL1 ARHGAP27 ARHGAP18 SOS2 | 3.01e-04 | 333 | 192 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | central nervous system development | EPHB3 DLG5 TOX MBD1 WASF3 NAGLU IKZF1 ARID1A FOXA2 SHC3 SLIT2 PTPRJ VPS13A PLXNA2 DMXL2 B3GLCT FOXN4 NR4A3 AGBL4 SLIT1 MAST1 IRS2 MDGA1 TNR | 3.26e-04 | 1197 | 192 | 24 | GO:0007417 |
| GeneOntologyBiologicalProcess | tube morphogenesis | EPHB3 DLG5 PSG6 PSG11 HIPK1 NAGLU ARID1A FOXA2 ADAM8 SLIT2 HEG1 PTPRJ DLG1 HAND2 CCDC40 ROCK2 FN1 FOXN4 TNC XDH NR4A3 APOB THBS2 | 3.33e-04 | 1125 | 192 | 23 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | EPHB3 DLG5 MAP1B IQSEC2 SLIT2 PTPRF KIF5B ROCK2 THBS2 SLIT1 MDGA1 PCDH8 | 3.45e-04 | 395 | 192 | 12 | GO:0050803 |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.74e-04 | 66 | 192 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | HIPK1 NAGLU CLASP2 ARID1A FOXA2 FREM2 PTPRQ DLG1 HAND2 CCDC40 ROCK2 TCF3 COL12A1 FN1 FOXN4 NR4A3 PCDH8 | 3.79e-04 | 713 | 192 | 17 | GO:0048598 |
| GeneOntologyBiologicalProcess | neural retina development | 3.86e-04 | 102 | 192 | 6 | GO:0003407 | |
| GeneOntologyBiologicalProcess | circulatory system development | EPHB3 PSG6 PSG11 HIPK1 MBD1 NAGLU PPP1R13L BCOR ARID1A ADAM8 SLIT2 FREM2 HEG1 PTPRJ DLX3 PLEC HAND2 CCDC40 ROCK2 FN1 FOXN4 XDH APOB CPE THBS2 ANKRD17 RBM24 | 4.01e-04 | 1442 | 192 | 27 | GO:0072359 |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 4.19e-04 | 38 | 192 | 4 | GO:0001779 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 4.29e-04 | 104 | 192 | 6 | GO:0030516 | |
| GeneOntologyBiologicalProcess | type B pancreatic cell proliferation | 4.64e-04 | 39 | 192 | 4 | GO:0044342 | |
| GeneOntologyBiologicalProcess | choline catabolic process | 5.11e-04 | 4 | 192 | 2 | GO:0042426 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 5.11e-04 | 4 | 192 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB3 MAP1B MCF2 CLASP2 SLIT2 PTPRF VPS13A KIF5B SDC2 PLXNA2 ROCK2 FN1 NR4A3 SLIT1 EIF2AK4 RND2 CTNND2 TNR | 5.23e-04 | 802 | 192 | 18 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 5.25e-04 | 71 | 192 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | EPHB3 MAP1B PSG6 PSG11 HIPK1 WASF3 MCF2 CLASP2 FOXA2 SLIT2 PTPRF DLG1 SDC2 PLXNA2 ROCK2 FN1 CPE THBS2 SLIT1 RND2 ARHGAP18 TNR | 5.37e-04 | 1090 | 192 | 22 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | EPPK1 PSG6 PSG11 NAGLU CLASP2 PPP1R13L FOXA2 ADAM8 SLIT2 IL22RA2 PTPRF PTPRJ ADAMTS18 LILRA2 TUT4 NAGK FN1 TNC RAB11FIP2 BIRC2 NDFIP1 SLIT1 ANKRD17 EIF2AK4 TNR | 5.42e-04 | 1316 | 192 | 25 | GO:0032101 |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 5.63e-04 | 41 | 192 | 4 | GO:1901889 | |
| GeneOntologyBiologicalProcess | regulation of cell development | TOX MAP1B PSG6 PSG11 MBD1 MCF2 IKZF1 ARID1A ADAM8 SLIT2 PTPRF PLXNA2 ROCK2 LILRA2 FN1 RFX3 NDFIP1 SLIT1 BRD7 RND2 TNR SOS2 | 5.70e-04 | 1095 | 192 | 22 | GO:0060284 |
| GeneOntologyBiologicalProcess | cytoplasm organization | 5.85e-04 | 18 | 192 | 3 | GO:0007028 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 5.85e-04 | 18 | 192 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 6.27e-04 | 202 | 192 | 8 | GO:0051963 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB3 TOX MAP1B MCF2 SLIT2 PTPRF SDC2 PLXNA2 ACAP3 FN1 FAT3 TENM3 SLIT1 RND2 TNR | 6.34e-04 | 612 | 192 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB3 MAP1B MCF2 CLASP2 SLIT2 PTPRF VPS13A KIF5B SDC2 PLXNA2 ROCK2 FN1 NR4A3 SLIT1 EIF2AK4 RND2 CTNND2 TNR | 6.67e-04 | 819 | 192 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction organization | 6.76e-04 | 75 | 192 | 5 | GO:0150116 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB3 MAP1B MCF2 CLASP2 SLIT2 PTPRF VPS13A KIF5B SDC2 PLXNA2 ROCK2 FN1 NR4A3 SLIT1 EIF2AK4 RND2 CTNND2 TNR | 7.35e-04 | 826 | 192 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | heart development | MBD1 NAGLU PPP1R13L BCOR ARID1A SLIT2 FREM2 HEG1 PTPRJ PLEC HAND2 CCDC40 ROCK2 FN1 FOXN4 CPE RBM24 | 7.43e-04 | 757 | 192 | 17 | GO:0007507 |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 8.46e-04 | 5 | 192 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | MAP1B PSG6 PSG11 FAT1 PTPRF PTPRJ ROCK2 RBM4 NR4A3 IRS2 SOS2 | 9.22e-04 | 381 | 192 | 11 | GO:0071375 |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | RBMXL1 RBMY1B IKZF1 ARID1A ADAM8 HEG1 PTPRJ NFIL3 DLG1 SGF29 HAND2 ROCK2 RHBDD1 TCF3 LILRA2 TUT4 FN1 TNC RBM4B RBM4 NR4A3 APOB RBMY1F BRD7 EIF2AK4 RBM24 | 9.41e-04 | 1446 | 192 | 26 | GO:0010628 |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 9.42e-04 | 382 | 192 | 11 | GO:0043491 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 9.97e-04 | 270 | 192 | 9 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 9.98e-04 | 217 | 192 | 8 | GO:1903034 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | EPPK1 PSG6 PSG11 CLASP2 ADAM8 ITGB4 ITGB7 SLIT2 PLEC HAND2 ROCK2 LAMTOR2 FN1 IRS2 | 1.06e-03 | 577 | 192 | 14 | GO:0001667 |
| GeneOntologyBiologicalProcess | negative regulation of transferase activity | 1.08e-03 | 273 | 192 | 9 | GO:0051348 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | EPHB3 DLG5 ABCA3 MAP1B MYOC IQSEC2 IKZF1 CLASP2 SLIT2 PTPRJ DLG1 ROCK2 ARHGEF5 THBS2 | 1.15e-03 | 582 | 192 | 14 | GO:0044089 |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.18e-03 | 126 | 192 | 6 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.23e-03 | 23 | 192 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 1.26e-03 | 86 | 192 | 5 | GO:0051965 | |
| GeneOntologyBiologicalProcess | regulation of cell size | 1.26e-03 | 225 | 192 | 8 | GO:0008361 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 1.26e-03 | 6 | 192 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | negative regulation of translation in response to stress | 1.26e-03 | 6 | 192 | 2 | GO:0032055 | |
| GeneOntologyBiologicalProcess | presynaptic cytoskeleton organization | 1.26e-03 | 6 | 192 | 2 | GO:0099187 | |
| GeneOntologyBiologicalProcess | positive regulation of centrosome duplication | 1.26e-03 | 6 | 192 | 2 | GO:0010825 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast growth factor production | 1.26e-03 | 6 | 192 | 2 | GO:0090271 | |
| GeneOntologyCellularComponent | anchoring junction | DLG5 EPPK1 PSG6 PSG11 PCDHB5 CLASP2 ITGB4 ITGB7 FAT1 HEG1 PTPRJ PI4KA DLG1 PLEC FLNC TNC ARHGEF5 CDH22 LAT CGNL1 CTNND2 CDH6 CDH7 CDH12 CDH18 | 5.11e-06 | 976 | 196 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | catenin complex | 1.13e-05 | 32 | 196 | 5 | GO:0016342 | |
| GeneOntologyCellularComponent | adherens junction | 3.31e-05 | 212 | 196 | 10 | GO:0005912 | |
| GeneOntologyCellularComponent | cell-cell junction | DLG5 EPPK1 PSG6 PSG11 PCDHB5 FAT1 HEG1 PTPRJ DLG1 CDH22 LAT CGNL1 CTNND2 CDH6 CDH7 CDH12 CDH18 | 4.44e-05 | 591 | 196 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | hemidesmosome | 1.27e-04 | 11 | 196 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | MYOC ITGB4 SLIT2 FREM2 ADAMDEC1 DLG1 SDC2 PLXNA2 COL12A1 FN1 CILP TNC THBS2 PLXDC2 TNR | 1.50e-04 | 530 | 196 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | MYOC ITGB4 SLIT2 FREM2 ADAMDEC1 ADAMTS18 DLG1 MMP10 SDC2 PLXNA2 COL12A1 FN1 CILP TNC THBS2 PLXDC2 TNR | 1.57e-04 | 656 | 196 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | MYOC ITGB4 SLIT2 FREM2 ADAMDEC1 ADAMTS18 DLG1 MMP10 SDC2 PLXNA2 COL12A1 FN1 CILP TNC THBS2 PLXDC2 TNR | 1.63e-04 | 658 | 196 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | plasma membrane protein complex | PSG6 PSG11 ADAM8 ITGB4 ITGB7 DLG1 LILRA2 BIRC2 KCNG3 ATP1B4 CDH22 GNB5 ABCB8 ATP1B3 CDH6 CDH7 CDH12 CDH18 | 4.45e-04 | 785 | 196 | 18 | GO:0098797 |
| GeneOntologyCellularComponent | tenascin complex | 5.18e-04 | 4 | 196 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | basement membrane | 1.03e-03 | 122 | 196 | 6 | GO:0005604 | |
| Domain | FN3_dom | EPHB3 ITGB4 IGSF22 IL22RA2 PTPRF PTPRJ FLNC SDK2 COL12A1 FN1 TNC MDGA1 TNR | 3.32e-07 | 209 | 196 | 13 | IPR003961 |
| Domain | CA | 3.69e-07 | 115 | 196 | 10 | SM00112 | |
| Domain | Cadherin | 4.70e-07 | 118 | 196 | 10 | IPR002126 | |
| Domain | EGF_1 | ADAM8 ITGB4 ITGB7 SLIT2 FAT1 HEG1 PEAR1 FN1 TNC FAT3 THBS2 TENM3 SLIT1 TNR | 5.31e-07 | 255 | 196 | 14 | PS00022 |
| Domain | FN3 | EPHB3 ITGB4 IGSF22 PTPRF PTPRJ FLNC SDK2 COL12A1 FN1 TNC MDGA1 TNR | 6.09e-07 | 185 | 196 | 12 | SM00060 |
| Domain | EGF-like_CS | ADAM8 ITGB4 ITGB7 SLIT2 FAT1 HEG1 PEAR1 FN1 TNC FAT3 THBS2 TENM3 SLIT1 TNR | 7.01e-07 | 261 | 196 | 14 | IPR013032 |
| Domain | FN3 | EPHB3 ITGB4 IGSF22 IL22RA2 PTPRF PTPRJ SDK2 COL12A1 FN1 TNC MDGA1 TNR | 1.32e-06 | 199 | 196 | 12 | PS50853 |
| Domain | Cadherin_CS | 2.22e-06 | 109 | 196 | 9 | IPR020894 | |
| Domain | CADHERIN_1 | 2.99e-06 | 113 | 196 | 9 | PS00232 | |
| Domain | Cadherin | 2.99e-06 | 113 | 196 | 9 | PF00028 | |
| Domain | CADHERIN_2 | 3.22e-06 | 114 | 196 | 9 | PS50268 | |
| Domain | - | 3.22e-06 | 114 | 196 | 9 | 2.60.40.60 | |
| Domain | Cadherin-like | 3.72e-06 | 116 | 196 | 9 | IPR015919 | |
| Domain | EGF_2 | ADAM8 ITGB4 ITGB7 SLIT2 FAT1 HEG1 PEAR1 TNC FAT3 THBS2 TENM3 SLIT1 TNR | 4.73e-06 | 265 | 196 | 13 | PS01186 |
| Domain | Cadherin_C | 5.42e-06 | 25 | 196 | 5 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 5.42e-06 | 25 | 196 | 5 | IPR000233 | |
| Domain | fn3 | 8.36e-06 | 162 | 196 | 10 | PF00041 | |
| Domain | Catenin_binding_dom | 1.17e-05 | 29 | 196 | 5 | IPR027397 | |
| Domain | - | 1.17e-05 | 29 | 196 | 5 | 4.10.900.10 | |
| Domain | - | EPHB3 PSG6 PSG11 CEACAM3 ITGB4 IGSF22 IL22RA2 PTPRF PTPRJ PXDNL PLXNA2 FLNC LILRA2 SDK2 COL12A1 FN1 CILP TNC MDGA1 TNR | 2.32e-05 | 663 | 196 | 20 | 2.60.40.10 |
| Domain | Laminin_G | 3.18e-05 | 58 | 196 | 6 | IPR001791 | |
| Domain | EGF_extracell | 3.87e-05 | 60 | 196 | 6 | IPR013111 | |
| Domain | EGF_2 | 3.87e-05 | 60 | 196 | 6 | PF07974 | |
| Domain | EGF | 3.98e-05 | 235 | 196 | 11 | SM00181 | |
| Domain | EGF_3 | 3.98e-05 | 235 | 196 | 11 | PS50026 | |
| Domain | Ig-like_fold | EPHB3 PSG6 PSG11 CEACAM3 ITGB4 IGSF22 IL22RA2 PTPRF PTPRJ PXDNL PLXNA2 FLNC LILRA2 SDK2 COL12A1 FN1 CILP TNC MDGA1 TNR | 5.59e-05 | 706 | 196 | 20 | IPR013783 |
| Domain | RBM1CTR | 6.13e-05 | 8 | 196 | 3 | PF08081 | |
| Domain | RBM1CTR | 6.13e-05 | 8 | 196 | 3 | IPR012604 | |
| Domain | EGF-like_dom | 6.71e-05 | 249 | 196 | 11 | IPR000742 | |
| Domain | Vitellinogen_b-sht_N | 1.10e-04 | 2 | 196 | 2 | IPR015816 | |
| Domain | Lipid_transp_b-sht_shell | 1.10e-04 | 2 | 196 | 2 | IPR015819 | |
| Domain | - | 1.10e-04 | 2 | 196 | 2 | 2.30.230.10 | |
| Domain | ARHGEF5_35 | 1.10e-04 | 2 | 196 | 2 | PF15441 | |
| Domain | VITELLOGENIN | 1.10e-04 | 2 | 196 | 2 | PS51211 | |
| Domain | ARHGEF5/35_N | 1.10e-04 | 2 | 196 | 2 | IPR029212 | |
| Domain | LPD_N | 1.10e-04 | 2 | 196 | 2 | SM00638 | |
| Domain | Lipid_transpt_N | 1.10e-04 | 2 | 196 | 2 | IPR001747 | |
| Domain | - | 1.10e-04 | 2 | 196 | 2 | 1.25.10.20 | |
| Domain | Vitellogenin_N | 1.10e-04 | 2 | 196 | 2 | PF01347 | |
| Domain | ARM-type_fold | USP34 GBF1 CLTCL1 CLASP2 ARID1A TRIP12 PIK3R4 PI4KA APOB FRYL EFR3B CTNND2 | 2.54e-04 | 339 | 196 | 12 | IPR016024 |
| Domain | RFX1_trans_act | 3.26e-04 | 3 | 196 | 2 | IPR007668 | |
| Domain | Vitellinogen_superhlx | 3.26e-04 | 3 | 196 | 2 | IPR011030 | |
| Domain | RFX1_trans_act | 3.26e-04 | 3 | 196 | 2 | PF04589 | |
| Domain | - | 4.96e-04 | 95 | 196 | 6 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 6.57e-04 | 38 | 196 | 4 | PS50025 | |
| Domain | CarboxyPept-like_regulatory | 6.94e-04 | 17 | 196 | 3 | IPR008969 | |
| Domain | Laminin_G_2 | 8.00e-04 | 40 | 196 | 4 | PF02210 | |
| Domain | IGc2 | 8.66e-04 | 235 | 196 | 9 | SM00408 | |
| Domain | Ig_sub2 | 8.66e-04 | 235 | 196 | 9 | IPR003598 | |
| Domain | Na/K_ATPase_sub_beta | 1.07e-03 | 5 | 196 | 2 | IPR000402 | |
| Domain | Na_K-ATPase | 1.07e-03 | 5 | 196 | 2 | PF00287 | |
| Domain | ATPASE_NA_K_BETA_1 | 1.07e-03 | 5 | 196 | 2 | PS00390 | |
| Domain | PSI | 1.15e-03 | 44 | 196 | 4 | IPR016201 | |
| Domain | LamG | 1.15e-03 | 44 | 196 | 4 | SM00282 | |
| Domain | PSI | 1.36e-03 | 46 | 196 | 4 | SM00423 | |
| Domain | - | 1.60e-03 | 6 | 196 | 2 | 3.90.1290.10 | |
| Domain | zf-CCHC | 1.73e-03 | 23 | 196 | 3 | PF00098 | |
| Domain | EGF_CA | 1.83e-03 | 122 | 196 | 6 | SM00179 | |
| Domain | GroES-like | 1.96e-03 | 24 | 196 | 3 | IPR011032 | |
| Domain | EGF-like_Ca-bd_dom | 1.98e-03 | 124 | 196 | 6 | IPR001881 | |
| Domain | EGF | 2.15e-03 | 126 | 196 | 6 | PF00008 | |
| Domain | aa-tRNA-synth_Ia | 2.22e-03 | 7 | 196 | 2 | IPR002300 | |
| Domain | Plectin | 2.22e-03 | 7 | 196 | 2 | PF00681 | |
| Domain | tRNA-synt_1 | 2.22e-03 | 7 | 196 | 2 | PF00133 | |
| Domain | Quin_OxRdtase/zeta-crystal_CS | 2.22e-03 | 7 | 196 | 2 | IPR002364 | |
| Domain | Integrin_B_tail | 2.22e-03 | 7 | 196 | 2 | SM01242 | |
| Domain | QOR_ZETA_CRYSTAL | 2.22e-03 | 7 | 196 | 2 | PS01162 | |
| Domain | Plectin_repeat | 2.22e-03 | 7 | 196 | 2 | IPR001101 | |
| Domain | Integrin_bsu_tail | 2.22e-03 | 7 | 196 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 2.22e-03 | 7 | 196 | 2 | PF07965 | |
| Domain | PLEC | 2.22e-03 | 7 | 196 | 2 | SM00250 | |
| Domain | ConA-like_dom | 2.24e-03 | 219 | 196 | 8 | IPR013320 | |
| Domain | - | 2.48e-03 | 26 | 196 | 3 | 4.10.60.10 | |
| Domain | PH | 2.74e-03 | 278 | 196 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 2.81e-03 | 279 | 196 | 9 | PS50003 | |
| Domain | PH_domain | 2.88e-03 | 280 | 196 | 9 | IPR001849 | |
| Domain | - | IQSEC2 MCF2 SHC3 ACAP3 ROCK2 ARHGEF5 RALGPS2 MTMR6 IRS2 ARHGAP27 SOS2 | 2.89e-03 | 391 | 196 | 11 | 2.30.29.30 |
| Domain | TMC | 2.94e-03 | 8 | 196 | 2 | PF07810 | |
| Domain | INB | 2.94e-03 | 8 | 196 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 2.94e-03 | 8 | 196 | 2 | IPR002369 | |
| Domain | Calx_beta | 2.94e-03 | 8 | 196 | 2 | SM00237 | |
| Domain | Integrin_beta | 2.94e-03 | 8 | 196 | 2 | PF00362 | |
| Domain | TMC | 2.94e-03 | 8 | 196 | 2 | IPR012496 | |
| Domain | PH | 2.95e-03 | 229 | 196 | 8 | PF00169 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.51e-06 | 73 | 158 | 8 | MM15126 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.20e-05 | 96 | 158 | 8 | MM14592 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.49e-05 | 199 | 158 | 11 | M7253 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | PSG6 PSG11 ADAM8 ITGB4 ITGB7 MMP10 SDC2 COL12A1 FN1 TNC TMPRSS6 TNR | 3.38e-05 | 258 | 158 | 12 | MM14572 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.28e-05 | 84 | 158 | 7 | M7098 | |
| Pathway | WP_FOCAL_ADHESION | 4.86e-05 | 187 | 158 | 10 | MM15913 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 5.06e-05 | 117 | 158 | 8 | M19248 | |
| Pathway | WP_FOXA2_PATHWAY | 7.84e-05 | 21 | 158 | 4 | M42579 | |
| Pathway | WP_FOCAL_ADHESION | 8.19e-05 | 199 | 158 | 10 | M39402 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAM8 ITGB4 ITGB7 ADAMTS18 PLEC MMP10 SDC2 COL12A1 FN1 TNC TMPRSS6 TNR | 1.43e-04 | 300 | 158 | 12 | M610 |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 1.57e-04 | 46 | 158 | 5 | M39828 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.93e-04 | 48 | 158 | 5 | MM15069 | |
| Pathway | WP_ECTODERM_DIFFERENTIATION | 1.97e-04 | 142 | 158 | 8 | M39575 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.18e-04 | 27 | 158 | 4 | M27217 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 2.73e-04 | 80 | 158 | 6 | M800 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 3.57e-04 | 155 | 158 | 8 | M522 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 4.22e-04 | 121 | 158 | 7 | M39823 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 4.59e-04 | 14 | 158 | 3 | MM14923 | |
| Pubmed | USP34 TRIP12 ITGB4 ADCY3 PI4KA KIF5B ROCK2 DMXL2 FN1 EEF1G MTMR6 CRYZ TENM3 BAZ1A SLIT1 EMD | 6.31e-11 | 322 | 198 | 16 | 26514267 | |
| Pubmed | ITGB4 FREM2 LYVE1 PTPRF ADAMDEC1 PTPRJ FN1 TNC APOB MINPP1 PLXDC2 MDGA1 CDH6 | 3.32e-09 | 257 | 198 | 13 | 16335952 | |
| Pubmed | 4.36e-09 | 12 | 198 | 5 | 22102170 | ||
| Pubmed | ATP5PO MAP1B IQSEC2 CLASP2 ARID1A NDUFS2 PIK3R4 PI4KA DLG1 KIF5B PLEC ROCK2 FLNC DMXL2 FN1 TNC PCLO IDH3B AGBL4 DZANK1 EEF1G SLC44A1 GNB5 MAST1 CGNL1 CTNND2 PC TNR | 1.30e-08 | 1431 | 198 | 28 | 37142655 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 GBF1 MAP1B IQSEC2 MBD1 CLASP2 TRIP12 PIK3R4 PI4KA KIF5B PLEC ARHGEF5 PARP8 RAB11FIP2 RALGPS2 FRYL CEP192 ANKRD17 IRS2 CGNL1 PC | 2.62e-08 | 861 | 198 | 21 | 36931259 |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 5.43e-08 | 91 | 198 | 8 | 28558017 | |
| Pubmed | USP34 KBTBD8 CLASP2 BCOR TRIP12 ITGB4 ADCY3 PI4KA ADAMTS18 DLG1 PLEC TMX3 FN1 SGPP2 RALGPS2 APOB FRYL CEP192 MTMR6 SLC44A1 BAZ1A ANKRD17 EIF2AK4 | 6.92e-08 | 1084 | 198 | 23 | 11544199 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 EPPK1 GBF1 CLTCL1 TBKBP1 NAGLU CLASP2 ARID1A ITGB4 FAT1 HEG1 PTPRF NUAK1 PI4KA PLEC RAD51 FLNC FRYL CEP192 LARS2 KMT2D IRS2 PC | 9.74e-08 | 1105 | 198 | 23 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBKBP1 MAP1B RTEL1 WASF3 ANKMY1 CLASP2 ARID1A ADCY3 DFFB PTPRJ DLG1 XYLB TMX3 RHBDD1 TCF3 TUT4 RBM4 TMPRSS6 FRYL CEP192 PLXDC2 MAST1 ANKRD17 RASEF EIF2AK4 AADAT SOS2 | 1.13e-07 | 1489 | 198 | 27 | 28611215 |
| Pubmed | 2.08e-07 | 10 | 198 | 4 | 10861224 | ||
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 6.04e-07 | 29 | 198 | 5 | 22036570 | |
| Pubmed | 1.05e-06 | 234 | 198 | 10 | 36243803 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GBF1 CLASP2 PPP1R13L TRIP12 FAT1 ADAMTS18 SDK2 NAGK PLXDC2 BAZ1A IRS2 CTNND2 | 1.25e-06 | 361 | 198 | 12 | 26167880 |
| Pubmed | EPPK1 ATP5PO NDUFS2 DLG1 BEGAIN FN1 TNC RAB11FIP2 CPE DZANK1 MAST1 PC TNR | 1.29e-06 | 430 | 198 | 13 | 32581705 | |
| Pubmed | 1.32e-06 | 15 | 198 | 4 | 33833667 | ||
| Pubmed | HIPK1 MBD1 PPP1R13L TRIP12 PTPRF PLEC FLNC NAGK FN1 RBM4 RFX1 EEF1G KMT2D TENM3 BAZ1A | 1.72e-06 | 591 | 198 | 15 | 15231748 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 1.76e-06 | 16 | 198 | 4 | 21067603 | |
| Pubmed | 1.80e-06 | 5 | 198 | 3 | 10191097 | ||
| Pubmed | 1.86e-06 | 36 | 198 | 5 | 37497580 | ||
| Pubmed | MAP1B IQSEC2 NDUFS2 CHCHD3 PI4KA DLG1 KIF5B PLEC BEGAIN DMXL2 TUT4 PCLO RAB11FIP2 DZANK1 EEF1G GNB5 EMD CTNND2 COIL PC PCDH8 | 2.51e-06 | 1139 | 198 | 21 | 36417873 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.62e-06 | 202 | 198 | 9 | 33005030 | |
| Pubmed | FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. | 3.59e-06 | 6 | 198 | 3 | 18497885 | |
| Pubmed | BCOR ARID1A NDUFS2 CHCHD3 VPS13A TNC RBM4 NR4A3 IDH3B RFX1 IFIT1 KMT2D ANKRD17 IRS2 CTNND2 | 4.35e-06 | 638 | 198 | 15 | 31182584 | |
| Pubmed | 4.60e-06 | 20 | 198 | 4 | 20711475 | ||
| Pubmed | E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. | 4.60e-06 | 20 | 198 | 4 | 7806582 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 ATP5PO MAP1B NAGLU ITGB4 FAT1 HEG1 PTPRF PTPRJ TMEM245 KIF5B TMX3 ROCK2 RHBDD1 B3GLCT COL12A1 RBM4 MINPP1 TENM3 LRP11 ATP1B3 | 5.67e-06 | 1201 | 198 | 21 | 35696571 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GBF1 MAP1B HIPK1 MBD1 FOXA2 TRIP12 NFIL3 PI4KA KIF5B SGF29 FLNC ZCWPW1 RFX1 RFX3 KMT2D BAZ1A ANKRD17 | 9.34e-06 | 857 | 198 | 17 | 25609649 |
| Pubmed | Type II cadherins guide assembly of a direction-selective retinal circuit. | 9.90e-06 | 24 | 198 | 4 | 25126785 | |
| Pubmed | NAGLU CLASP2 PPP1R13L BCOR ARID1A PTPRF PTPRJ PI4KA VPS13A DLG1 PMS1 CEP192 MTMR6 KMT2D EFR3B EIF2AK4 EMD COIL PC | 9.93e-06 | 1049 | 198 | 19 | 27880917 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.00e-05 | 370 | 198 | 11 | 22922362 | |
| Pubmed | SHC3 PXDNL ADAMTS18 DLG1 XYLB TMX3 TUT4 RALGPS2 MINPP1 NDFIP1 AXDND1 DZANK1 CRYZ SYT14 EFR3B | 1.03e-05 | 686 | 198 | 15 | 29987050 | |
| Pubmed | USP34 CLASP2 TRIP12 FAT1 PI4KA VPS13A DLG1 FN1 APOB CEP192 EEF1G TENM3 CGNL1 EMD COIL PC | 1.09e-05 | 777 | 198 | 16 | 35844135 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EPHB3 USP34 GBF1 CLASP2 NDUFS2 FAT1 PTPRF PTPRJ VPS13A DLG1 RBFOX3 RBM4B APOB NDFIP1 CRYZ LRP11 ABCB8 NR5A2 PC | 1.16e-05 | 1061 | 198 | 19 | 33845483 |
| Pubmed | Activation of TrkB signaling mitigates cerebellar anomalies caused by Rbm4-Bdnf deficiency. | 1.49e-05 | 9 | 198 | 3 | 37670183 | |
| Pubmed | 1.49e-05 | 9 | 198 | 3 | 25056828 | ||
| Pubmed | 2.17e-05 | 146 | 198 | 7 | 27068509 | ||
| Pubmed | USP34 MBD1 BCOR ARID1A SLIT2 FAT1 FBXO5 XYLB TMX3 SGF29 TUT4 FAT3 BIRC2 C16orf96 IDH3B ZNF768 BRD7 ANKRD17 IRS2 | 2.33e-05 | 1116 | 198 | 19 | 31753913 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 ATP5PO MAP1B TRIP12 SLIT2 CHCHD3 PTPRF PI4KA KIF5B PLEC FLNC RBM4B RBM4 IDH3B EEF1G BAZ1A EMD COIL | 2.55e-05 | 1024 | 198 | 18 | 24711643 |
| Pubmed | 2.84e-05 | 31 | 198 | 4 | 37816598 | ||
| Pubmed | 2.90e-05 | 11 | 198 | 3 | 22902530 | ||
| Pubmed | Immunolocalization of extracellular matrix components and integrins during mouse liver development. | 2.90e-05 | 11 | 198 | 3 | 15368439 | |
| Pubmed | 3.18e-05 | 105 | 198 | 6 | 9628581 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 31589839 | ||
| Pubmed | Human placenta secretes apolipoprotein B-100-containing lipoproteins. | 3.22e-05 | 2 | 198 | 2 | 15504742 | |
| Pubmed | Tenascins and inflammation in disorders of the nervous system. | 3.22e-05 | 2 | 198 | 2 | 23269478 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 17499243 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 11328943 | ||
| Pubmed | Fibronectin fragments and the cleaving enzyme ADAM-8 in the degenerative human intervertebral disc. | 3.22e-05 | 2 | 198 | 2 | 25010013 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 23485472 | ||
| Pubmed | GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2. | 3.22e-05 | 2 | 198 | 2 | 33692332 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 15795421 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 28986537 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 15817481 | ||
| Pubmed | Phylogenetic and molecular characterization of the splicing factor RBM4. | 3.22e-05 | 2 | 198 | 2 | 23527094 | |
| Pubmed | A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion. | 3.22e-05 | 2 | 198 | 2 | 10713055 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 35850306 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 16262655 | ||
| Pubmed | Expression of DLG1 and DLG5 in the Intestinal Epithelium of Patients with CD. | 3.22e-05 | 2 | 198 | 2 | 27760079 | |
| Pubmed | Tenascins are associated with lipid rafts isolated from mouse brain. | 3.22e-05 | 2 | 198 | 2 | 12056833 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 24842304 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 35681468 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 29317724 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 11358959 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 23313574 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 20530568 | ||
| Pubmed | Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis. | 3.22e-05 | 2 | 198 | 2 | 20708078 | |
| Pubmed | Foxa2 may modulate hepatic apoptosis through the cIAP1 pathway. | 3.22e-05 | 2 | 198 | 2 | 23275033 | |
| Pubmed | Binding of tenascin-C to soluble fibronectin and matrix fibrils. | 3.22e-05 | 2 | 198 | 2 | 7499434 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 36788209 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 27487388 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 19056372 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 12515855 | ||
| Pubmed | The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum. | 3.22e-05 | 2 | 198 | 2 | 18708123 | |
| Pubmed | Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. | 3.22e-05 | 2 | 198 | 2 | 30451798 | |
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 3.22e-05 | 2 | 198 | 2 | 12200164 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 28702990 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 35418692 | ||
| Pubmed | Widespread aplasia cutis congenita in sibs with PLEC1 and ITGB4 variants. | 3.22e-05 | 2 | 198 | 2 | 31184804 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 9915855 | ||
| Pubmed | Two distinct steps of immigration of hematopoietic progenitors into the early thymus anlage. | 3.22e-05 | 2 | 198 | 2 | 11526101 | |
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 3.22e-05 | 2 | 198 | 2 | 10432110 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 10772816 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 9482226 | ||
| Pubmed | Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. | 3.22e-05 | 2 | 198 | 2 | 21813734 | |
| Pubmed | Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome. | 3.22e-05 | 2 | 198 | 2 | 31816409 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 24792713 | ||
| Pubmed | Novel mutations in abetalipoproteinaemia and homozygous familial hypobetalipoproteinaemia. | 3.22e-05 | 2 | 198 | 2 | 18027103 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 15627506 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 23320558 | ||
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 3.22e-05 | 2 | 198 | 2 | 12097499 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 14732481 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 1372909 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 33846772 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 20232238 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 19459213 | ||
| Pubmed | HSF4 is involved in DNA damage repair through regulation of Rad51. | 3.22e-05 | 2 | 198 | 2 | 22587838 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 17690102 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.66e-05 | 281 | 198 | 9 | 28706196 | |
| Pubmed | 3.66e-05 | 33 | 198 | 4 | 26071364 | ||
| Pubmed | Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids. | 3.85e-05 | 12 | 198 | 3 | 10090148 | |
| GeneFamily | CD molecules|Type II classical cadherins | 3.06e-08 | 13 | 139 | 5 | 1186 | |
| GeneFamily | Fibronectin type III domain containing | EPHB3 ITGB4 IGSF22 PTPRF PTPRJ PTPRQ SDK2 COL12A1 FN1 TNC TNR | 4.35e-08 | 160 | 139 | 11 | 555 |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.34e-04 | 21 | 139 | 3 | 813 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 9.04e-04 | 25 | 139 | 3 | 74 | |
| GeneFamily | RNA binding motif containing | 1.31e-03 | 213 | 139 | 7 | 725 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.59e-03 | 8 | 139 | 2 | 939 | |
| GeneFamily | Transmembrane channel likes | 1.59e-03 | 8 | 139 | 2 | 1135 | |
| GeneFamily | Regulatory factor X family | 1.59e-03 | 8 | 139 | 2 | 1153 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.67e-03 | 66 | 139 | 4 | 722 | |
| GeneFamily | CD molecules|Integrin beta subunits | 2.04e-03 | 9 | 139 | 2 | 1159 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 3.08e-03 | 11 | 139 | 2 | 1315 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 GBF1 MAP1B KDM4C WASF3 CLASP2 TRIP12 PIK3R4 SLIT2 FAT1 HEG1 NUAK1 VPS13A DLG1 PMS1 ROCK2 DMXL2 TUT4 FRYL LARS2 AZIN1 THBS2 BAZ1A ANKRD17 SOS2 | 7.41e-09 | 856 | 197 | 25 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAP1B WASF3 CLASP2 TRIP12 FAT1 HEG1 NUAK1 VPS13A PMS1 ROCK2 TUT4 FRYL LARS2 THBS2 BAZ1A ANKRD17 | 5.35e-07 | 466 | 197 | 16 | M13522 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | TOX FOXA2 SLIT2 FREM2 FAT1 SDC2 FAT3 RALGPS2 GRM8 CRYZ PLXDC2 RBM24 | 3.97e-06 | 307 | 197 | 12 | M39058 |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN | 3.97e-06 | 56 | 197 | 6 | M14036 | |
| Coexpression | PEREZ_TP53_TARGETS | EPHB3 DLG5 EPPK1 CLTCL1 TOX MCF2 BCOR HEG1 HOXC6 NUAK1 PTPRJ DLX3 ACAP3 PEAR1 FLNC CILP RBM4B CPE KCNG3 GRM8 IFIT1 BRD7 RASEF CGNL1 ARHGAP27 | 4.15e-06 | 1201 | 197 | 25 | M4391 |
| Coexpression | BENPORATH_EED_TARGETS | EPHB3 ARID1A FOXA2 PTGR3 SLIT2 HOXC6 ADAMTS18 DLX3 PLEC HSF4 SDC2 PLXNA2 HAND2 COL12A1 SGPP2 NR4A3 SLIT1 CTNND2 RBM24 ATP1B3 MDGA1 PCDH8 CDH7 | 5.23e-06 | 1059 | 197 | 23 | M7617 |
| Coexpression | BENPORATH_PRC2_TARGETS | EPHB3 FOXA2 PTGR3 SLIT2 HOXC6 ADAMTS18 DLX3 PLEC HSF4 PLXNA2 HAND2 SGPP2 NR4A3 SLIT1 CTNND2 PCDH8 CDH7 | 9.23e-06 | 650 | 197 | 17 | M8448 |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 9.41e-06 | 180 | 197 | 9 | M6878 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN | 2.10e-05 | 199 | 197 | 9 | M9599 | |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 2.10e-05 | 199 | 197 | 9 | M6538 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 2.86e-05 | 207 | 197 | 9 | M14566 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | EPHB3 CHDH FOXA2 PTGR3 SLIT2 HOXC6 ADAMTS18 DLX3 PLEC HSF4 PLXNA2 HAND2 COL12A1 PARP8 SGPP2 NR4A3 THBS2 SLIT1 CTNND2 CDH6 PCDH8 CDH7 | 3.68e-05 | 1115 | 197 | 22 | M10371 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | DLG5 NAGLU ADAM8 ITGB4 ADCY3 DFFB HEG1 PLEC PLXNA2 FLNC DMXL2 SDK2 FN1 CILP RFX1 LAT GNB5 CTNND2 PC | 6.04e-05 | 909 | 197 | 19 | M41018 |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 6.33e-05 | 178 | 197 | 8 | M17079 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | CHDH MBD1 BCOR SLIT2 NUAK1 PI4KA ADAMTS18 MMP10 SDC2 SYT13 DZANK1 CDH6 | 7.06e-05 | 411 | 197 | 12 | M1351 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | CHDH MBD1 BCOR SLIT2 NUAK1 PI4KA ADAMTS18 MMP10 SDC2 SYT13 DZANK1 CDH6 | 7.91e-05 | 416 | 197 | 12 | MM1002 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 9.74e-05 | 300 | 197 | 10 | M8702 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | GABRR2 MAP1B MYOC PPP1R13L ITGB4 SHC3 LYVE1 PTPRF PTPRQ DLG1 MMP10 HAND2 BEGAIN TCF3 TNC POLR2H APOB GRM8 CDH22 NR5A2 IRS2 CTNND2 TNR | 1.02e-04 | 1281 | 197 | 23 | M1884 |
| Coexpression | BENPORATH_SUZ12_TARGETS | EPHB3 FOXA2 PTGR3 SLIT2 HOXC6 ADAMTS18 DLX3 PLEC HSF4 SDC2 PLXNA2 HAND2 SGPP2 NR4A3 SLIT1 RASEF CTNND2 CDH6 PCDH8 CDH7 | 1.12e-04 | 1035 | 197 | 20 | M9898 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | SLIT2 FREM2 FAT1 SDC2 FLNC FAT3 RALGPS2 NR4A3 NDFIP1 CRYZ SLC44A1 SLIT1 MTTP TMC5 | 1.21e-04 | 574 | 197 | 14 | M39056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.24e-04 | 196 | 197 | 8 | M3008 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | 1.34e-04 | 312 | 197 | 10 | M39161 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 1.38e-04 | 199 | 197 | 8 | M5159 | |
| Coexpression | RATTENBACHER_BOUND_BY_CELF1 | IKZF1 ANKMY1 NDUFS2 PTGR3 ADAMDEC1 PLEC PLXNA2 FRYL RFX1 LAT EFR3B TMC5 | 1.46e-04 | 444 | 197 | 12 | M2505 |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.69e-04 | 261 | 197 | 9 | M1834 | |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 | 1.69e-04 | 108 | 197 | 6 | M2410 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | SLIT2 FREM2 HOXC6 FBXO5 NUAK1 PTPRJ RAD51 SDK2 ZCWPW1 B3GLCT TNC FAT3 PARP8 PCLO CEP192 TENM3 PLXDC2 BAZ1A RASEF BBS12 CDH6 | 6.86e-06 | 749 | 197 | 21 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | SLIT2 FREM2 HOXC6 FBXO5 NUAK1 PTPRJ TNC FAT3 CEP192 TENM3 PLXDC2 BAZ1A BBS12 CDH6 | 9.93e-06 | 370 | 197 | 14 | gudmap_kidney_P3_CapMes_Crym_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | DLG5 SLIT2 FREM2 HEG1 HOXC6 NFIL3 SRL SDC2 PLXNA2 FLNC ZCWPW1 COL12A1 FN1 FAT3 RAB11FIP2 CPE KCNG3 TENM3 PLXDC2 CDH6 CDH12 | 1.74e-05 | 797 | 197 | 21 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | FREM2 HOXC6 FBXO5 NUAK1 PTPRJ B3GLCT TNC FAT3 PLXDC2 RASEF BBS12 CDH6 | 1.87e-05 | 291 | 197 | 12 | gudmap_kidney_P2_CapMes_Crym_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | EPHB3 MAP1B BCOR ARID1A SLIT2 FAT1 HEG1 FBXO5 NUAK1 VPS13A CCDC40 PMS1 TCF3 TUT4 FAT3 PARP8 FRYL LARS2 RFX3 DZANK1 BAZ1A SLIT1 SYT14 EFR3B IRS2 RND2 MDGA1 CDH6 SOS2 | 2.68e-05 | 1370 | 197 | 29 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | WASF3 HOXC6 FBXO5 NUAK1 PTPRJ ZCWPW1 B3GLCT TNC FAT3 PARP8 FRYL IDH3B RFX3 TENM3 PLXDC2 RASEF BBS12 CDH6 | 3.02e-05 | 639 | 197 | 18 | gudmap_kidney_P0_CapMes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TOX MAP1B KBTBD8 IKZF1 SHC3 SLIT2 FREM2 HEG1 VPS13A XYLB ROCK2 TUT4 RBFOX3 FAT3 PCLO NR4A3 FRYL LARS2 BAZ1A LRP11 MAST1 CTNND2 CDH7 | 4.84e-05 | 989 | 197 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TOX MAP1B RTEL1 WASF3 ARID1A FOXA2 SLIT2 HEG1 ADAMDEC1 VPS13A ADAMTS18 XYLB CCDC40 TUT4 FAT3 NR4A3 CEP192 LARS2 RFX3 DZANK1 BAZ1A CTNND2 MDGA1 CDH6 | 5.01e-05 | 1060 | 197 | 24 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000 | FREM2 HOXC6 FBXO5 NUAK1 PTPRJ ZCWPW1 B3GLCT TNC FAT3 PARP8 TENM3 PLXDC2 BAZ1A RASEF TUBE1 BBS12 CDH6 | 9.61e-05 | 636 | 197 | 17 | gudmap_kidney_P2_CapMes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB3 TOX GLB1L SLIT2 FAT1 PLXNA2 NAGK RBFOX3 FAT3 PARP8 PCLO BIRC2 CPE LARS2 DZANK1 MAST1 CDH7 | 1.44e-04 | 658 | 197 | 17 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | SLIT2 HOXC6 NUAK1 NFIL3 PLXNA2 FLNC SDK2 FN1 TNC RAB11FIP2 NR4A3 CPE KCNG3 AZIN1 TENM3 RASEF EMD CDH6 CDH12 CDH18 | 1.50e-04 | 858 | 197 | 20 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | SLIT2 FREM2 HEG1 HOXC6 SRL SDC2 PLXNA2 FLNC ZCWPW1 COL12A1 FN1 FAT3 RAB11FIP2 KCNG3 THBS2 TENM3 PLXDC2 CDH6 CDH12 | 1.66e-04 | 797 | 197 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB3 TOX GLB1L SLIT2 FAT1 PLXNA2 NAGK RBFOX3 FAT3 PCLO BIRC2 CPE LARS2 DZANK1 LRP11 GNB5 MAST1 CDH7 | 1.69e-04 | 732 | 197 | 18 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 2.10e-04 | 13 | 197 | 3 | gudmap_kidney_P2_CapMes_Crym_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 2.31e-04 | 93 | 197 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | EPHB3 MAP1B BCOR SHC3 SLIT2 FAT3 PCLO FRYL LARS2 BAZ1A LRP11 MAST1 CTNND2 CDH7 | 2.31e-04 | 496 | 197 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | MAP1B IKZF1 SHC3 FREM2 ROCK2 RBFOX3 FAT3 PCLO FRYL LARS2 BAZ1A LRP11 CTNND2 CDH7 | 2.41e-04 | 498 | 197 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TOX MAP1B RTEL1 WASF3 ARID1A FOXA2 SHC3 SLIT2 HEG1 ADAMDEC1 VPS13A ADAMTS18 XYLB CCDC40 TUT4 FAT3 XDH NR4A3 CEP192 LARS2 RFX3 DZANK1 BAZ1A SLIT1 CTNND2 MDGA1 CDH6 | 2.84e-04 | 1414 | 197 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.90e-04 | 97 | 197 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | MAP1B CLASP2 FREM2 LYVE1 ADAMDEC1 KIF5B HAND2 ROCK2 FLNC COL12A1 RBFOX3 TNC ASAH2 NR4A3 ATP1B4 THBS2 SLC44A1 CTNND2 | 3.23e-04 | 772 | 197 | 18 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.23e-04 | 139 | 197 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | cerebral cortex | MAP1B WASF3 MCF2 CLASP2 SHC3 NUAK1 SYT13 BEGAIN RBFOX3 FAT3 PCLO AMER3 KCNG3 GRM8 AGBL4 CDH22 SLIT1 SYT14 EFR3B MAST1 RND2 CTNND2 TNR PCDH8 CDH7 CDH12 CDH18 | 3.32e-04 | 1428 | 197 | 27 | cerebral cortex |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_1000 | EPPK1 PPP1R13L FOXA2 ADAM8 ITGB4 IGSF22 NFIL3 DLX3 PLEC MMP10 HSF4 SDK2 FN1 TNC ARHGEF5 PCLO SGPP2 XDH ARHGEF35 LRP11 RASEF | 3.51e-04 | 987 | 197 | 21 | PCBC_ctl_SmallAirwayEpithel_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.73e-04 | 236 | 197 | 9 | gudmap_kidney_P3_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05 | MAP1B FAT1 NUAK1 SDC2 SDK2 COL12A1 RFX3 THBS2 SLIT1 RND2 CDH6 | 3.97e-04 | 345 | 197 | 11 | PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05 |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | MAP1B SLIT2 FAT1 HOXC6 DLX3 SDC2 COL12A1 FN1 TNC FAT3 CPE THBS2 TENM3 | 6.30e-12 | 200 | 197 | 13 | 3c898e81444b001835c3f1bbc68183078701b135 |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | MAP1B SLIT2 FAT1 HOXC6 DLX3 SDC2 COL12A1 FN1 TNC FAT3 CPE THBS2 TENM3 | 6.30e-12 | 200 | 197 | 13 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EPPK1 FAT1 PTPRF PTPRJ SDC2 FLNC FN1 LARS2 THBS2 SLC44A1 PLXDC2 IRS2 | 6.58e-11 | 192 | 197 | 12 | 0dc1f46e40346ed0b286e53b106a812441575100 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | SLIT2 FAT1 DLX3 SDC2 SYT13 HAND2 COL12A1 FN1 TNC FAT3 CPE ATP1B4 | 9.40e-11 | 198 | 197 | 12 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | SLIT2 FAT1 DLX3 SDC2 SYT13 HAND2 COL12A1 FN1 TNC FAT3 CPE ATP1B4 | 9.40e-11 | 198 | 197 | 12 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | MAP1B SLIT2 FAT1 DLX3 SDC2 COL12A1 FN1 TNC FAT3 CPE THBS2 TENM3 | 1.06e-10 | 200 | 197 | 12 | 780d47f8eff630020dfae32218de495a7e9dbad6 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | MAP1B SLIT2 FAT1 DLX3 SDC2 COL12A1 FN1 TNC FAT3 CPE THBS2 TENM3 | 1.06e-10 | 200 | 197 | 12 | 28dd127787a57276253548d1f030814b1af64481 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.95e-10 | 191 | 197 | 11 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.38e-09 | 197 | 197 | 11 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.38e-09 | 197 | 197 | 11 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.38e-09 | 197 | 197 | 11 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-09 | 198 | 197 | 11 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-09 | 198 | 197 | 11 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-09 | 198 | 197 | 11 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-09 | 198 | 197 | 11 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-09 | 198 | 197 | 11 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-09 | 199 | 197 | 11 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-09 | 199 | 197 | 11 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-09 | 199 | 197 | 11 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-09 | 199 | 197 | 11 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.62e-09 | 200 | 197 | 11 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.24e-09 | 180 | 197 | 10 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.16e-09 | 182 | 197 | 10 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.16e-09 | 182 | 197 | 10 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.66e-09 | 183 | 197 | 10 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-08 | 195 | 197 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-08 | 195 | 197 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-08 | 196 | 197 | 10 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-08 | 196 | 197 | 10 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-08 | 196 | 197 | 10 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-08 | 197 | 197 | 10 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-08 | 198 | 197 | 10 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-07 | 178 | 197 | 9 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 178 | 197 | 9 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-07 | 179 | 197 | 9 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-07 | 182 | 197 | 9 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-07 | 185 | 197 | 9 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.60e-07 | 187 | 197 | 9 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.67e-07 | 188 | 197 | 9 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.83e-07 | 190 | 197 | 9 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-07 | 191 | 197 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 191 | 197 | 9 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.91e-07 | 191 | 197 | 9 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-07 | 191 | 197 | 9 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.91e-07 | 191 | 197 | 9 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-07 | 191 | 197 | 9 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.91e-07 | 191 | 197 | 9 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-07 | 192 | 197 | 9 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.00e-07 | 192 | 197 | 9 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.28e-07 | 195 | 197 | 9 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.28e-07 | 195 | 197 | 9 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-07 | 196 | 197 | 9 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-07 | 196 | 197 | 9 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-07 | 198 | 197 | 9 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-07 | 200 | 197 | 9 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 6.20e-07 | 161 | 197 | 8 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-07 | 171 | 197 | 8 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-06 | 177 | 197 | 8 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-06 | 178 | 197 | 8 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-06 | 178 | 197 | 8 | ccea3c8908d72f5fecd151a133048c8e9758304c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-06 | 181 | 197 | 8 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-06 | 183 | 197 | 8 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 184 | 197 | 8 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-06 | 184 | 197 | 8 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-06 | 184 | 197 | 8 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-06 | 184 | 197 | 8 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-06 | 185 | 197 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.84e-06 | 186 | 197 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.84e-06 | 186 | 197 | 8 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 186 | 197 | 8 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-06 | 188 | 197 | 8 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 188 | 197 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.99e-06 | 188 | 197 | 8 | 263169029293e005bcffd87db20221fdd2d3917e | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-06 | 189 | 197 | 8 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 2.07e-06 | 189 | 197 | 8 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-06 | 189 | 197 | 8 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-06 | 189 | 197 | 8 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.07e-06 | 189 | 197 | 8 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-06 | 189 | 197 | 8 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.15e-06 | 190 | 197 | 8 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 190 | 197 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-06 | 190 | 197 | 8 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 191 | 197 | 8 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.24e-06 | 191 | 197 | 8 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 191 | 197 | 8 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 191 | 197 | 8 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-06 | 192 | 197 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 2.33e-06 | 192 | 197 | 8 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 192 | 197 | 8 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-06 | 192 | 197 | 8 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-06 | 192 | 197 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.33e-06 | 192 | 197 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-06 | 193 | 197 | 8 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.42e-06 | 193 | 197 | 8 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-06 | 193 | 197 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.42e-06 | 193 | 197 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.42e-06 | 193 | 197 | 8 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 194 | 197 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 194 | 197 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 194 | 197 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | EPHB3 MBD1 SLIT2 SYT13 ROCK2 CILP PCLO RALGPS2 XDH IFIT1 SLC44A1 EFR3B | 1.97e-07 | 200 | 198 | 12 | 6509_UP |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.75e-06 | 193 | 198 | 10 | 3627_DN | |
| Drug | Rgd Peptide | PSG6 PSG11 ITGB4 ITGB7 PIK3R4 SDC2 COL12A1 FN1 TNC THBS2 TNR | 8.39e-06 | 239 | 198 | 11 | CID000104802 |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | GABRR2 GLB1L LYVE1 PLXNA2 BEGAIN TUT4 TMPRSS6 APOB SLC44A1 IRS2 | 8.87e-06 | 196 | 198 | 10 | 4499_UP |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; HL60; HT_HG-U133A | 8.87e-06 | 196 | 198 | 10 | 2531_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | USP34 RTEL1 GLB1L IKZF1 ADAM8 SDC2 FN1 TMPRSS6 RALGPS2 EFR3B | 9.28e-06 | 197 | 198 | 10 | 1485_UP |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 9.28e-06 | 197 | 198 | 10 | 6083_UP | |
| Drug | Esculetin [305-01-1]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 9.70e-06 | 198 | 198 | 10 | 6499_UP | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.70e-06 | 198 | 198 | 10 | 6508_UP | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 9.70e-06 | 198 | 198 | 10 | 2622_UP | |
| Drug | Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.01e-05 | 199 | 198 | 10 | 6815_UP | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; PC3; HT_HG-U133A | 3.21e-05 | 182 | 198 | 9 | 2049_UP | |
| Drug | AC1L1IPV | 3.48e-05 | 43 | 198 | 5 | CID000004683 | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 3.81e-05 | 186 | 198 | 9 | 5930_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; PC3; HT_HG-U133A | 5.08e-05 | 193 | 198 | 9 | 6760_UP | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 5.08e-05 | 193 | 198 | 9 | 6751_DN | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 5.28e-05 | 194 | 198 | 9 | 6380_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.28e-05 | 194 | 198 | 9 | 3377_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; PC3; HT_HG-U133A | 5.50e-05 | 195 | 198 | 9 | 6626_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 5.50e-05 | 195 | 198 | 9 | 1665_DN | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; PC3; HT_HG-U133A | 5.72e-05 | 196 | 198 | 9 | 3999_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.72e-05 | 196 | 198 | 9 | 6003_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 2889_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 2849_DN | |
| Drug | Sulmazole [73384-60-8]; Up 200; 14uM; PC3; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 4009_UP | |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; HL60; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 3031_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 2265_DN | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 2636_UP | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 5390_UP | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; PC3; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 6749_UP | |
| Drug | MK-886; Down 200; 1uM; MCF7; HG-U133A | 6.43e-05 | 199 | 198 | 9 | 264_DN | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; PC3; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 7306_UP | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; HL60; HG-U133A | 6.43e-05 | 199 | 198 | 9 | 1771_UP | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 6.68e-05 | 200 | 198 | 9 | 5603_DN | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 6.68e-05 | 200 | 198 | 9 | 6030_UP | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; HL60; HG-U133A | 6.68e-05 | 200 | 198 | 9 | 1980_UP | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 6.68e-05 | 200 | 198 | 9 | 5230_DN | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; PC3; HT_HG-U133A | 6.68e-05 | 200 | 198 | 9 | 3741_UP | |
| Drug | AC1L9Q83 | 7.52e-05 | 2 | 198 | 2 | CID000452314 | |
| Drug | panobinostat | TOX GLB1L PPP1R13L SHC3 SLIT2 HEG1 PTPRF DLX3 PLXNA2 BEGAIN RBFOX3 FAT3 SGPP2 CPE RFX3 THBS2 BAZ1A SLIT1 RASEF CGNL1 CTNND2 RBM24 ARHGAP18 TMC5 PCDH8 CDH18 | 9.71e-05 | 1333 | 198 | 26 | ctd:C496932 |
| Disease | retinal detachment, retinal break | 2.91e-06 | 35 | 190 | 5 | EFO_0005773, EFO_0010698 | |
| Disease | Colorectal Carcinoma | ABCA3 MAP1B ARID1A FAT1 VPS13A ADAMTS18 FLNC TCF3 FN1 PARP8 APOB CPE CDH22 GNB5 CTNND2 CDH7 | 1.39e-05 | 702 | 190 | 16 | C0009402 |
| Disease | vital capacity | EPHB3 USP34 TRIP12 ADCY3 HOXC6 ADAMTS18 DLG1 XYLB RHBDD1 FN1 PCLO RALGPS2 C16orf96 APOB CPE THBS2 SYT14 NR5A2 EFR3B MTTP PC SOS2 | 1.68e-05 | 1236 | 190 | 22 | EFO_0004312 |
| Disease | Junctional epidermolysis bullosa with pyloric atresia | 4.12e-05 | 2 | 190 | 2 | cv:C5676875 | |
| Disease | Epidermolysis Bullosa Simplex With Pyloric Atresia | 4.12e-05 | 2 | 190 | 2 | C2677349 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA | 4.12e-05 | 2 | 190 | 2 | 226730 | |
| Disease | Burkitt Lymphoma | 8.35e-05 | 36 | 190 | 4 | C0006413 | |
| Disease | cortical thickness | SLIT2 PTPRF NUAK1 PI4KA ADAMTS18 KIF5B PLEC SGF29 PLXNA2 COL12A1 FAT3 RALGPS2 AGBL4 PLXDC2 BAZ1A LRP11 ARHGAP18 ATP1B3 SOS2 | 1.12e-04 | 1113 | 190 | 19 | EFO_0004840 |
| Disease | African Burkitt's lymphoma | 1.13e-04 | 15 | 190 | 3 | C0343640 | |
| Disease | Burkitt Leukemia | 1.13e-04 | 15 | 190 | 3 | C4721444 | |
| Disease | Epidermolysis bullosa with pyloric atresia | 1.23e-04 | 3 | 190 | 2 | C1856934 | |
| Disease | T-Cell Lymphoma | 1.38e-04 | 16 | 190 | 3 | C0079772 | |
| Disease | Astrocytosis | 1.67e-04 | 17 | 190 | 3 | C3887640 | |
| Disease | Gliosis | 1.67e-04 | 17 | 190 | 3 | C0017639 | |
| Disease | parahippocampal gyrus volume measurement | 2.00e-04 | 18 | 190 | 3 | EFO_0010318 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.02e-04 | 45 | 190 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | neuroimaging measurement | MAP1B NAGLU SLIT2 CASTOR1 NUAK1 ADAMTS18 PLEC PLXNA2 FAT3 RALGPS2 FRYL BAZ1A LRP11 ARHGAP27 ARHGAP18 TMC5 ATP1B3 PC | 2.03e-04 | 1069 | 190 | 18 | EFO_0004346 |
| Disease | Hepatic fibrosis | 2.81e-04 | 49 | 190 | 4 | HP_0001395 | |
| Disease | Lumbar disc disease | 4.07e-04 | 5 | 190 | 2 | C0221775 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 4.07e-04 | 5 | 190 | 2 | 603932 | |
| Disease | Intervertebral disc disorder | 4.07e-04 | 5 | 190 | 2 | cv:C0158252 | |
| Disease | Disorder of eye | 4.68e-04 | 212 | 190 | 7 | C0015397 | |
| Disease | smoking status measurement | GBF1 TOX CHDH ADCY3 SLIT2 CHCHD3 PTPRF PXDNL PLXNA2 FAT3 MON1B GRM8 RFX3 AGBL4 SYT14 CTNND2 MDGA1 CDH12 | 5.36e-04 | 1160 | 190 | 18 | EFO_0006527 |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 6.08e-04 | 6 | 190 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | Intervertebral disc disorder | 6.08e-04 | 6 | 190 | 2 | C0158252 | |
| Disease | Aplasia Cutis Congenita | 6.08e-04 | 6 | 190 | 2 | C0282160 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 6.13e-04 | 26 | 190 | 3 | EFO_0010366 | |
| Disease | retinal detachment | 8.48e-04 | 7 | 190 | 2 | EFO_0005773 | |
| Disease | white matter microstructure measurement | 1.01e-03 | 390 | 190 | 9 | EFO_0005674 | |
| Disease | Embryonal Rhabdomyosarcoma | 1.13e-03 | 8 | 190 | 2 | C0206656 | |
| Disease | female breast cancer (is_implicated_in) | 1.13e-03 | 8 | 190 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Diabetes Mellitus | 1.14e-03 | 32 | 190 | 3 | C0011849 | |
| Disease | colorectal cancer (is_implicated_in) | 1.14e-03 | 121 | 190 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | alcohol consumption measurement | DLG5 KDM4C CHDH WASF3 DFFB PTPRJ XYLB SGF29 PLXNA2 COL12A1 PCLO SGPP2 KCNG3 SYT14 MTTP ARHGAP27 CTNND2 CDH18 | 1.17e-03 | 1242 | 190 | 18 | EFO_0007878 |
| Disease | pursuit maintenance gain measurement | 1.23e-03 | 123 | 190 | 5 | EFO_0008433 | |
| Disease | joint hypermobility measurement | 1.24e-03 | 33 | 190 | 3 | EFO_0007905 | |
| Disease | mucocutaneous lymph node syndrome | 1.49e-03 | 76 | 190 | 4 | EFO_0004246 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 1.79e-03 | 10 | 190 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.79e-03 | 10 | 190 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | abdominal aortic calcification measurement | 1.79e-03 | 10 | 190 | 2 | EFO_0010272 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 1.79e-03 | 10 | 190 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | Hypercholesterolemia | 2.03e-03 | 39 | 190 | 3 | C0020443 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 2.18e-03 | 11 | 190 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 2.18e-03 | 11 | 190 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | Colorectal Neoplasms | 2.20e-03 | 277 | 190 | 7 | C0009404 | |
| Disease | diabetes mellitus (is_marker_for) | 2.34e-03 | 41 | 190 | 3 | DOID:9351 (is_marker_for) | |
| Disease | cognitive function measurement | USP34 GBF1 KDM4C CHCHD3 PTPRF TMEM245 DMXL2 RBFOX3 CEP192 MINPP1 GRM8 NDFIP1 THBS2 KMT2D MAST1 CTNND2 ATP1B3 TNR CDH7 | 2.38e-03 | 1434 | 190 | 19 | EFO_0008354 |
| Disease | autistic disorder (is_implicated_in) | 2.51e-03 | 42 | 190 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | waist-hip ratio | NAGLU TRIP12 ADCY3 PTGR3 HOXC6 CASTOR1 DLG1 RAD51 DMXL2 FN1 CEP192 NDFIP1 AGBL4 SLC44A1 NR5A2 EFR3B ATP1B3 | 2.53e-03 | 1226 | 190 | 17 | EFO_0004343 |
| Disease | breast carcinoma | KDM4C MBD1 ADCY3 PXDNL ARHGEF5 PARP8 CEP192 NDFIP1 GNB5 SYT14 EFR3B MAST1 PADI6 ARHGAP27 CDH12 | 2.58e-03 | 1019 | 190 | 15 | EFO_0000305 |
| Disease | hyperinsulinism (is_implicated_in) | 2.61e-03 | 12 | 190 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.61e-03 | 12 | 190 | 2 | C0023485 | |
| Disease | Calcium channel blocker use measurement | 2.65e-03 | 213 | 190 | 6 | EFO_0009930 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.07e-03 | 13 | 190 | 2 | C1846647 | |
| Disease | reticulocyte measurement | USP34 KBTBD8 IKZF1 ADCY3 FAT1 PTPRJ NFIL3 VPS13A TMC8 TMPRSS6 AZIN1 BAZ1A MAST1 IRS2 EIF2AK4 | 3.51e-03 | 1053 | 190 | 15 | EFO_0010700 |
| Disease | Hamman-Rich syndrome | 3.57e-03 | 14 | 190 | 2 | C0085786 | |
| Disease | transferrin receptor protein 1 measurement | 3.57e-03 | 14 | 190 | 2 | EFO_0802142 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 3.57e-03 | 14 | 190 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | platelet crit | RTEL1 IKZF1 ARID1A PTGR3 HOXC6 PLEC HAND2 CCDC40 ZCWPW1 TMPRSS6 POLR2H APOB NDFIP1 IRS2 | 3.60e-03 | 952 | 190 | 14 | EFO_0007985 |
| Disease | neuroticism measurement, cognitive function measurement | 3.84e-03 | 566 | 190 | 10 | EFO_0007660, EFO_0008354 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.89e-03 | 49 | 190 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | USP34 MAP1B MBD1 PIK3R4 PXDNL KIF5B B3GLCT FN1 FAT3 RALGPS2 FRYL THBS2 PLXDC2 SLIT1 EIF2AK4 CTNND2 ATP1B3 SOS2 | 3.98e-03 | 1392 | 190 | 18 | EFO_0005763 |
| Disease | Adenoid Cystic Carcinoma | 4.04e-03 | 100 | 190 | 4 | C0010606 | |
| Disease | phosphoenolpyruvic acid measurement | 4.10e-03 | 15 | 190 | 2 | EFO_0010522 | |
| Disease | lysophosphatidylcholine 14:0 measurement | 4.10e-03 | 15 | 190 | 2 | EFO_0010356 | |
| Disease | serum alanine aminotransferase measurement | DLG5 GBF1 ARID1A PTPRJ ADAMTS18 COL12A1 PCLO XDH APOB MTTP RASEF CDH6 SOS2 | 4.31e-03 | 869 | 190 | 13 | EFO_0004735 |
| Disease | platelet measurement | 4.46e-03 | 315 | 190 | 7 | EFO_0005036 | |
| Disease | Diabetic Angiopathies | 4.66e-03 | 16 | 190 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 4.66e-03 | 16 | 190 | 2 | C0025945 | |
| Disease | Small cell carcinoma of lung | 5.12e-03 | 54 | 190 | 3 | C0149925 | |
| Disease | age at menarche | USP34 KDM4C ARID1A ADCY3 CHCHD3 TMEM245 XYLB BEGAIN DZANK1 SLIT1 | 5.35e-03 | 594 | 190 | 10 | EFO_0004703 |
| Disease | response to lithium ion | 5.67e-03 | 56 | 190 | 3 | GO_0010226 | |
| Disease | mean reticulocyte volume | KDM4C MBD1 IKZF1 DFFB PTPRF PTPRJ VPS13A SRL AZIN1 MAST1 IRS2 CDH6 | 5.83e-03 | 799 | 190 | 12 | EFO_0010701 |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 5.90e-03 | 18 | 190 | 2 | EFO_0006831, EFO_0006896 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NYADYSLRSTEEPTA | 96 | Q7L8C5 | |
| TFPRDSYSGDALYEL | 411 | Q8N944 | |
| AFYVDSSAPSPYLRA | 386 | Q8N5Z0 | |
| YSDYTENSIPTVDLG | 301 | Q6Y288 | |
| SQRISPAIDYTYDSD | 1036 | Q9P2K8 | |
| SDLIYSTYGEDSDLP | 426 | Q9NPI1 | |
| LSVEDIGAYSYPVSA | 421 | Q9BUH8 | |
| IGAYSYPVSAAGRAS | 426 | Q9BUH8 | |
| DGRASPLYASYKADS | 461 | Q9BUH8 | |
| EPGSYYVSSAFTLAV | 271 | O14977 | |
| GPLAAADISAYYIST | 286 | Q8WTX7 | |
| ETSSDNSGQTRYYSP | 171 | Q12774 | |
| SLETPTYVNGTDADY | 206 | Q12959 | |
| ETSSDNSGQTRYYSP | 171 | A5YM69 | |
| TSGRAYISGYEISQD | 586 | Q99758 | |
| SIASAYRESPDSCYS | 361 | Q96P50 | |
| SYLREVSSYPSTVGA | 166 | O76075 | |
| DYRGSTTTLYQPSAT | 2716 | Q8TDJ6 | |
| RDLLGSGYTETYTAA | 76 | P78325 | |
| VSDYTPLSLAASGGY | 1181 | O75179 | |
| SYGADPTLATYSGRT | 1551 | Q6W2J9 | |
| ATDSGSPSSYILNEY | 626 | Q6ZW61 | |
| TLPESSVTDLGYYSA | 31 | O60479 | |
| STLYRNSYGAPAEDI | 1121 | Q9UQB3 | |
| ENDIRSISYYPESAS | 276 | Q9UN42 | |
| GIEGRYATALYSAAS | 36 | P48047 | |
| TEDTYLRFDEYGSSG | 266 | Q8TE60 | |
| SKPTYSRGRSSNAYD | 951 | Q9NRL2 | |
| ASAGSESRDEYSYVV | 31 | Q8NE62 | |
| SSEPSYLAAATTAVY | 321 | P54802 | |
| PYLSESYLITTDAAG | 96 | Q9UJ70 | |
| DPREAYGSSSYVASI | 466 | A6NDE4 | |
| DPREAYGSSSYVASI | 466 | Q15415 | |
| AAAASTTPYIDYTGA | 141 | Q9BX46 | |
| VTAASTSYYGRDRSP | 296 | Q9BWF3 | |
| VRYSIPEETESGYSV | 31 | Q9Y5E4 | |
| PLGYDRSSRSSYVDE | 396 | Q8IZ41 | |
| SSTISGGYAEYALAA | 96 | Q08257 | |
| DEGIPITSASYYATV | 111 | Q5T6V5 | |
| VDSATALYRTDYSGR | 221 | Q06609 | |
| PAAAAAAYSDSYGRV | 276 | A6NFN3 | |
| ESDINSVRYYPSGDA | 281 | O14775 | |
| SALAEGSTYVPYRDS | 266 | P33176 | |
| SDTYTFYSADEPGVL | 121 | Q8TAE7 | |
| SEYSDPLELVVTGAY | 106 | Q8N149 | |
| PIYSRYGSVEALSAT | 121 | Q7L1V2 | |
| YGNAYPATATAATER | 1431 | O14497 | |
| SYEVRLTPYTTFGAG | 716 | Q8NFP4 | |
| PSYLDAAYEVNSRDT | 336 | P09238 | |
| YYLTVEATDGGTPSL | 3301 | Q14517 | |
| SPSVDADKVSVTYYG | 91 | Q6TGC4 | |
| GLIDGAESYVSFSRY | 946 | Q12913 | |
| GPRSVSYSVHVSEDY | 46 | Q8N3A8 | |
| YSSYSLSRAPDGAAL | 181 | Q86VZ4 | |
| TTRTPEEGGYSYDIS | 1946 | P46821 | |
| RSSYYVVSGNDPAAE | 2381 | P46821 | |
| EFIVSDSTYSVASPY | 161 | Q9Y5Y7 | |
| EGSSPADNRYSEYAE | 586 | Q9Y217 | |
| LYTYAAPTSAAALGS | 1111 | Q86Z02 | |
| RLPGSYDSTSSDSLY | 31 | O43561 | |
| YDSTSSDSLYPRGIQ | 36 | O43561 | |
| YEAASTIYGPHTLSA | 591 | Q9NR71 | |
| DASYPLQDTTGYTAR | 136 | Q5JU85 | |
| TSVLSYSDYISRPED | 1931 | Q5SZK8 | |
| SDTYYQSPTGDRIRS | 31 | Q9UIS9 | |
| ESSRAPFQYTEGYTT | 3691 | Q9Y6V0 | |
| YDSSFRYTGSPDSLR | 1621 | O75051 | |
| AYTGYIERSPRSAST | 616 | P55157 | |
| PAYAGSYLVVTAASL | 441 | O95206 | |
| AVAYSSGRLDGSEYV | 791 | Q5VY43 | |
| EPRDDRGSYTASIYQ | 231 | Q16649 | |
| SIDYALTGSYDGAVS | 346 | Q9Y2G0 | |
| NGTEDESYEYRPRSS | 86 | O94915 | |
| RDNGDGTYTVSYLPD | 1591 | Q14315 | |
| SSYSPDVSDYKEGRI | 486 | P38432 | |
| VRIASSYYPEGDGDS | 1071 | Q8TDM6 | |
| PLESTGAVVYSGSLY | 321 | Q99972 | |
| DGTALEPEYYFSTIS | 291 | P42356 | |
| AYAYRSVPSISSEAD | 471 | Q9H3R0 | |
| YGQYSRPAEFETTSE | 531 | P54753 | |
| TSETSDIQEPYYGRV | 121 | Q969J5 | |
| ISSYDGEYAQPSTES | 611 | Q9ULI3 | |
| KGLSDTPYDSSASYE | 286 | Q13422 | |
| AAATTSSYYGRDRSP | 291 | Q9BQ04 | |
| YASTAPELSDNTRYD | 176 | O00222 | |
| VAPGYYTLTADQDAR | 916 | P16144 | |
| YRSTPDSAYLGASSQ | 1141 | Q9Y2H9 | |
| EFGVYLVSDGSSRPY | 406 | O75306 | |
| NGLYSRSTEFDYPSV | 316 | P26010 | |
| DIYIAGGYRPSSSEV | 336 | Q8NFY9 | |
| SQRYSGAYGASVSDE | 46 | Q9NX63 | |
| ADASVPGSDYINASY | 2081 | Q9UMZ3 | |
| VVFSSSRGPYDYGSN | 61 | P09630 | |
| ALSYSPEYASGAAGL | 61 | P61296 | |
| EDSYGLVAPATAAYR | 181 | Q9Y4H2 | |
| SYNVATTLPSYDEAE | 66 | Q9BT67 | |
| TAYIDGSNVYGSSER | 891 | A1KZ92 | |
| STDSASYYPLTGDTR | 986 | P04114 | |
| LSAATGRPYRDTAAY | 21 | Q96HJ9 | |
| VPGESYSAEYAVFET | 291 | O43837 | |
| GDPTEYYSTAIVTVE | 496 | Q8N9C0 | |
| DSEIYEILSPSYSAA | 641 | A6NNT2 | |
| YRISVFATYSSGEGE | 971 | Q99715 | |
| LSTDGGSLYEAPVSY | 1276 | Q0VF96 | |
| GSLYEAPVSYTFSKD | 1281 | Q0VF96 | |
| LETSRLYEDSGYSSF | 136 | Q9UKT4 | |
| YRIVYSPSVEGSSTE | 841 | P02751 | |
| TGAGRDISFLYDVTY | 121 | Q5T1B0 | |
| YYTETSSPEGQISAA | 96 | Q4G0X9 | |
| DPDDGANSRITYSLY | 2626 | Q8TDW7 | |
| TTSYDYDAPISEAGD | 326 | Q6UWU2 | |
| SYIISGTTAAVPYTE | 406 | Q5VU57 | |
| DLVANYPYDETRSGS | 251 | P16870 | |
| YSAEYSVSLPSDPDR | 16 | O60266 | |
| YYSTDTALPEEGGRT | 646 | Q9P2S6 | |
| PGAAYSGRETIYTNA | 91 | P40198 | |
| TIYSTPESRTASYLG | 471 | Q9ULV5 | |
| ESGEGSDRYPSYSFK | 741 | P10911 | |
| ESSAGYAISAYRLDG | 176 | P09914 | |
| LLAYSGYGDTDARVT | 31 | Q9Y2Q5 | |
| GVSRLTYVSEPESSY | 1036 | Q8TEP8 | |
| ADDPTYGNSARVVYS | 186 | Q13634 | |
| SLDRGYTSDSEVYTD | 1311 | Q92538 | |
| RGGSSYPSNLVYSTE | 26 | A1A580 | |
| ATGAAARLVSGYDSY | 51 | Q8WWI5 | |
| ATYAYEGTGSVADSL | 736 | P55285 | |
| LATYAYEGSGSVAES | 736 | P55289 | |
| DDPTYGSSARLVYSV | 196 | Q9UJ99 | |
| AYYVSNEELRGSTPE | 76 | P26641 | |
| EESYFTTRTYGEPES | 96 | P50402 | |
| DDPTYGNSARVVYSI | 181 | Q9ULB5 | |
| SDTPDVNIYYTLDGS | 36 | Q9NVP4 | |
| PSVTSYYSGENLDLS | 246 | Q9UQ72 | |
| YLDNSSIEEASGVYP | 31 | P34741 | |
| SGVYPIDDDDYASAS | 41 | P34741 | |
| RAQAYSYTESDSGEP | 2096 | Q58EX2 | |
| YLQPDAYGSLDRATS | 126 | Q8WUF5 | |
| TADDQRYSGSTYLSD | 796 | P54277 | |
| RYSGSTYLSDPRLTA | 801 | P54277 | |
| YSESEANSLAGYPRS | 381 | P28476 | |
| TTRYSIGGLSPFSEY | 371 | P10586 | |
| GLTPETTYSVTVAAY | 786 | P10586 | |
| LSDLTYIDSAYPSTG | 206 | Q86X27 | |
| YIDSAYPSTGSILEN | 211 | Q86X27 | |
| AEGEYSDGYRSSSLL | 46 | Q9NUT2 | |
| TGLDASPLAADTSYY | 431 | Q9Y261 | |
| PSISTFVEGYSSNYE | 56 | Q92570 | |
| SRAIKSEYPDPYTSS | 266 | O00482 | |
| VTGLYTAYSTPDSVA | 481 | Q96NZ1 | |
| GSFSETISAYYARVA | 596 | Q9NZ71 | |
| TISAYYARVAAPGST | 601 | Q9NZ71 | |
| PLSAEYDGYSSEASI | 131 | Q8NB59 | |
| EAPRNYDTYTAGLSE | 256 | Q8TEB9 | |
| SVERGYPSSRDSYSS | 351 | Q96E39 | |
| PSSSGELNYYDLVRT | 191 | Q07890 | |
| LTAYTATPEAIYGTS | 296 | Q15031 | |
| YYEAAGTATQVSTPA | 331 | P22670 | |
| YETAEGVSLPRSTLY | 446 | P22670 | |
| YETAEGVSLPRSTLY | 191 | P48380 | |
| GPAYSGRETVYSNAS | 91 | Q00889 | |
| LLSAERAVTGYTDPY | 681 | P58107 | |
| LSAERAVTGYTDPYT | 2301 | P58107 | |
| LLSAERAVTGYTDPY | 2836 | P58107 | |
| LLSAERAVTGYTDPY | 3901 | P58107 | |
| LSAERAVTGYTDPYT | 4436 | P58107 | |
| AERAVTGYTDPYTGQ | 4971 | P58107 | |
| SLTSYPEEDYSPVGS | 366 | Q6ZUM4 | |
| YISRIYGPSDSASRD | 116 | Q6UX71 | |
| ASGGDPDTTDYVAYV | 256 | Q92529 | |
| SGYYSSPERSESSEL | 476 | O60285 | |
| VSDYYSPTRADTTTI | 266 | Q8IWX5 | |
| VEDISSSRTNPYSYA | 166 | Q13490 | |
| DYTETLYSPRGEEIT | 101 | O15204 | |
| LEYTFSRSDPTSYAG | 91 | P54709 | |
| SRSDPTSYAGYIEDL | 96 | P54709 | |
| SPDAYSAYVLASLAG | 816 | O75339 | |
| NSYIRGDDPSSYLEV | 1126 | P53675 | |
| RSTGALYAPEVYGAS | 556 | O75122 | |
| PYEEIYGVSSTKTSA | 151 | Q8WW14 | |
| AYPERSYVVAGSTSS | 1271 | Q99570 | |
| SYSSIASEFGVRGYP | 86 | Q96JJ7 | |
| DTSGSSYYDNVRPLA | 61 | P52198 | |
| LESDVAYASYIPGSI | 306 | Q9H0M4 | |
| VGPESSSVYSIRLAY | 191 | Q8IU68 | |
| LYEAIGYSETAVDPT | 466 | Q96RL7 | |
| SSLSPYFGTKTRYED | 41 | Q9UNW1 | |
| EDYGRDATAYPSAKT | 191 | P15923 | |
| YRFVTSIYPSGEDDV | 171 | Q9UJT0 | |
| SVLFEDTSYADGYSP | 261 | Q96ES7 | |
| YQLYTGAEPTTSEFT | 121 | Q86TD4 | |
| PDTRSHASDVTDYSY | 236 | Q9UPY6 | |
| PAIATVDSYVISYTG | 1821 | P24821 | |
| RTSYTLTDLEPGAEY | 736 | Q92752 | |
| ASLFLGSYSPIDYSD | 201 | O75191 | |
| EPRSPGYESESSRYE | 136 | Q9H5H4 | |
| DTPFYADSLVGTYSK | 291 | O75116 | |
| YDSTRVSFTYDETAG | 1961 | Q9P273 | |
| SIEIPYSREGEYFSA | 406 | P47989 | |
| TEAATRLSAYVSYGG | 106 | P52434 | |
| RASYDTGSHPASAIY | 1216 | O94813 | |
| PFDATAGYRSLTYEE | 441 | Q7L804 | |
| TGYRDPYSGSTISLF | 3571 | Q15149 | |
| RSYVDPSTDERLSYT | 3981 | Q15149 | |
| PRYYSSGSLSAGDDA | 26 | Q96GW9 | |
| AGEEATSSRRYGQYT | 31 | Q8N392 | |
| ASDINYSAGRYDPSV | 76 | Q8N4Q0 | |
| PTYFVDTAIYSDISG | 786 | Q9H330 | |
| PDYSGTRSNAYSAAS | 81 | Q6UXY8 | |
| RESTGSYSDLYPDSD | 1456 | Q70CQ2 | |
| EDQPTRAYGYSGVSL | 1051 | P35442 | |
| VRVSYDPGSYPSSAI | 1221 | O75093 | |
| VLYEVYSSSAGPAVR | 841 | Q14669 | |
| IGDASRGSLSSYAYI | 1111 | Q5TAX3 | |
| SYSELAEGAAYAGAS | 461 | A7MCY6 | |
| YTGDVADPSRTKYSL | 706 | P11498 | |
| AAYRASLVSKSYSEP | 326 | O94900 | |
| STVNSSAAVPYRAEY | 181 | Q8IU80 | |
| SATALYPVGYEATRI | 5201 | O14686 |